![logo](/logos/300677.SZ.webp)
Intco Medical Technology Co., Ltd.
SZSE:300677.SZ
22.44 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 6,918.724 | 6,613.814 | 16,240.094 | 13,836.715 | 2,082.935 | 1,892.54 | 1,750.478 | 1,183.107 | 998.022 | 884.713 | 713.279 |
Cost of Revenue
| 5,971.023 | 5,745.717 | 6,251.626 | 4,285.31 | 1,560.112 | 1,420.502 | 1,314.298 | 893.304 | 734.831 | 726.574 | 607.03 |
Gross Profit
| 947.702 | 868.097 | 9,988.468 | 9,551.404 | 522.823 | 472.039 | 436.18 | 289.803 | 263.19 | 158.139 | 106.248 |
Gross Profit Ratio
| 0.137 | 0.131 | 0.615 | 0.69 | 0.251 | 0.249 | 0.249 | 0.245 | 0.264 | 0.179 | 0.149 |
Reseach & Development Expenses
| 283.373 | 252.323 | 365.225 | 293.301 | 67.595 | 62.559 | 56.914 | 38.148 | 28.734 | 24.882 | 20.47 |
General & Administrative Expenses
| 153.471 | 130.103 | 285.488 | 132.698 | 34.829 | 31.036 | 25.006 | 22.375 | 34.494 | 12.831 | 50.732 |
Selling & Marketing Expenses
| 251.802 | 217.827 | 383.712 | 323.635 | 132.366 | 119.638 | 106.661 | 92.244 | 86.332 | 46.492 | 25.74 |
SG&A
| 405.273 | 347.93 | 669.2 | 456.334 | 167.195 | 150.674 | 131.667 | 114.619 | 120.826 | 59.323 | 76.472 |
Other Expenses
| 179.395 | 298.311 | 281.988 | 158.661 | 63.6 | 2.695 | -5.589 | 0.738 | -0.521 | -1.08 | 0.067 |
Operating Expenses
| 1,048.659 | 898.564 | 1,316.413 | 908.296 | 298.39 | 276.91 | 232.392 | 186.622 | 178.681 | 107.538 | 78.206 |
Operating Income
| 438.99 | 707.184 | 8,688.725 | 8,368.929 | 202.454 | 203.511 | 168.446 | 100.217 | 78.381 | 39.74 | 10.731 |
Operating Income Ratio
| 0.063 | 0.107 | 0.535 | 0.605 | 0.097 | 0.108 | 0.096 | 0.085 | 0.079 | 0.045 | 0.015 |
Total Other Income Expenses Net
| 3.828 | -2.77 | -40.032 | -22.291 | 0.819 | 11.485 | -40.931 | -5.046 | -10.393 | -13.27 | -17.306 |
Income Before Tax
| 442.818 | 704.414 | 8,648.693 | 8,346.638 | 203.273 | 206.614 | 162.857 | 98.135 | 74.116 | 37.331 | 10.737 |
Income Before Tax Ratio
| 0.064 | 0.107 | 0.533 | 0.603 | 0.098 | 0.109 | 0.093 | 0.083 | 0.074 | 0.042 | 0.015 |
Income Tax Expense
| 54.753 | 65.071 | 1,185.221 | 1,342.127 | 25.006 | 27.275 | 17.773 | 11.873 | 9.896 | 5.582 | 0.042 |
Net Income
| 382.998 | 629.07 | 7,430.076 | 7,007.048 | 178.316 | 179.339 | 145.084 | 86.263 | 64.22 | 31.854 | 10.697 |
Net Income Ratio
| 0.055 | 0.095 | 0.458 | 0.506 | 0.086 | 0.095 | 0.083 | 0.073 | 0.064 | 0.036 | 0.015 |
EPS
| 0.58 | 0.99 | 11.37 | 12.21 | 0.34 | 0.34 | 0.32 | 0.22 | 0.19 | 0.1 | 0.037 |
EPS Diluted
| 0.58 | 0.95 | 11 | 11.31 | 0.33 | 0.34 | 0.32 | 0.22 | 0.19 | 0.1 | 0.037 |
EBITDA
| 1,323.564 | 1,404.331 | 9,098.55 | 8,523.608 | 322.56 | 306.596 | 250.3 | 154.759 | 124.88 | 78.458 | 53.781 |
EBITDA Ratio
| 0.191 | 0.212 | 0.56 | 0.616 | 0.155 | 0.162 | 0.143 | 0.131 | 0.125 | 0.089 | 0.075 |